Rheumatoid Arthritis Terminated Phase 2 Trials for Toreforant (DB12522)

Also known as: Rheumatoid Arthritis(RA) / Rheumatoid Arthritis, NOS / Rheumatoid Arthritis RA / Rhematoid Arthritis / Rheumatic Arthritis / Rheumatoid Arthritis (RA) / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Arthritis, Rheumatoid (RA) / Rheumatoid Arthritis(RA) / RA / Systemic rheumatoid arthritis / Rheumatoid arthritis (disorder) / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Rheumatoid arthritis NOS / Rheumatoid arthritis NOS (disorder)

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01679951A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With MethotrexateTreatment
NCT00941707An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid ArthritisTreatment
NCT01862224A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate TherapyTreatment